AVXL — Anavex Life Sciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Anavex Life Sciences, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	2019 September 30th	2020 September 30th	2021 September 30th	2022 September 30th	2023 September 30th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	22.2	29.2	152	149	151
Net Total Receivables	2.64	4.85	9.14	3.19	2.71
Prepaid Expenses
Total Other Current Assets
Total Current Assets	25.3	34.5	162	153	154
Other Long Term Assets
Total Assets	25.3	34.5	162	153	154
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	5.04	7.31	10.8	10.2	12.5
Total Long Term Debt
Total Debt
Total Liabilities	5.04	7.31	10.8	10.2	12.5
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	20.3	27.2	151	142	142
Total Liabilities & Shareholders' Equity	25.3	34.5	162	153	154
Total Common Shares Outstanding